{
    "2019-06-03": [
        [
            {
                "time": "2019-01-01",
                "original_text": "High-Yield Stocks",
                "features": {
                    "keywords": [
                        "High-Yield",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Comparing Pfizer’s and Merck’s Vaccines Businesses",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Merck",
                        "Vaccines",
                        "Businesses"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "How Is Pfizer’s Biopharmaceuticals Group Positioned in 2019?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Biopharmaceuticals",
                        "Positioned",
                        "2019"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "How Losses of Exclusivity Are Playing Out for PFE and MRK in 2019",
                "features": {
                    "keywords": [
                        "Losses",
                        "Exclusivity",
                        "PFE",
                        "MRK",
                        "2019"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Merck's Keytruda Improves 5-Year Survival in Lung Cancer",
                "features": {
                    "keywords": [
                        "Merck",
                        "Keytruda",
                        "Survival",
                        "Lung",
                        "Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Blueprint Medicines' NDA for Avapritinib on Track for GIST",
                "features": {
                    "keywords": [
                        "Blueprint",
                        "Medicines",
                        "NDA",
                        "Avapritinib",
                        "GIST"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Comparing Pfizer’s and Merck’s 2019 Revenue Growth Trajectories",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Merck",
                        "Revenue",
                        "Growth",
                        "2019"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "What Analysts Are Expecting from Pfizer and Merck in June",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Expecting",
                        "Pfizer",
                        "Merck",
                        "June"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "XLV, EGPT: Big ETF Outflows",
                "features": {
                    "keywords": [
                        "XLV",
                        "EGPT",
                        "ETF",
                        "Outflows"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 04, 2019",
                "features": {
                    "keywords": [
                        "Phibro",
                        "Animal",
                        "Health",
                        "PAHC",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled",
                        "June",
                        "04",
                        "2019"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "Matinas BioPharma to Present at the 9th Annual LD Micro Invitational",
                "features": {
                    "keywords": [
                        "Matinas",
                        "BioPharma",
                        "Present",
                        "LD",
                        "Micro",
                        "Invitational"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}